2-(2-Ethyl-2h-tetrazol-5-yl)-ethylamine → 1-(6-Bromo-imidazo[1,2-a]pyridin-2-yl)-3-[2-(2-ethyl-2h-tetrazol-5-yl)-ethyl]-urea
반응식
[Br:1][C:2]1[CH:3]=[CH:4][C:5]2[N:6]([CH:8]=[C:9]([NH:11][C:12]([NH:14][CH2:15][CH2:16][C:17]3[N:18]=[N:19][N:20]([CH:22](C)[CH3:23])[N:21]=3)=[O:13])[N:10]=2)[CH:7]=1.Cl.C(N1N=NC(CCN)=N1)(C)C.C(N1N=NC(CCN)=N1)C>>[Br:1][C:2]1[CH:3]=[CH:4][C:5]2[N:6]([CH:8]=[C:9]([NH:11][C:12]([NH:14][CH2:15][CH2:16][C:17]3[N:18]=[N:19][N:20]([CH2:22][CH3:23])[N:21]=3)=[O:13])[N:10]=2)[CH:7]=1참가 물질
4
반응물 3
생성물 1
실험 절차
This compound is prepared analogously to Intermediate E1 (described in preparation of intermediates section) by replacing 2-(2-isopropyl-2H-tetrazol-5-yl)-ethylamine hydrochloride (Intermediate D1) with 2-(2-ethyl-2H-tetrazol-5-yl)-ethylamine (Intermediate D2).
출처 및 근거
- ORD 기록
- ord-3756083e3e7943c4b45912e910617685
- 출처 데이터셋
- uspto-grants-2011_11
- 특허 번호
- US08053574B2
반응 노트
불러오는 중…